We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current XRTX market cap is 7.05M. The company's latest EPS is CAD -1.0801 and P/E is -2.37.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -368k | -1.14M | -2.42M | -12.33M | -5.53M |
| Net Income | -629k | -1.28M | -1.65M | -9.49M | -2.16M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.09M | 2.29M | 22.04M | 16.75M | 5.47M |
| Total Liabilities | 1.3M | 1.03M | 5.3M | 7.29M | 826k |
| Total Equity | -211k | 1.26M | 16.74M | 9.47M | 4.64M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -249k | -728k | -6.06M | -11.97M | -6.58M |
| Investing | -7k | -14k | -40k | -60k | -46k |
| Financing | 55k | 855k | 24.46M | 6.43M | -361k |
| Market Cap | 7.05M |
| Price to Earnings Ratio | -2.37 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.48 |
| Price to Book Ratio | 1.1 |
| Dividend Yield | - |
| Shares Outstanding | 2M |
| Average Volume (1 week) | 7.88k |
| Average Volume (1 Month) | 5.01k |
| 52 Week Change | 287.91% |
| 52 Week High | 9.35 |
| 52 Week Low | 0.33 |
| Spread (Intraday) | 0.73 (17.18%) |
| Company Name | Xortx Therapeutics Inc |
| Address |
550 burrard street, suite 2900 vancouver, british columbia V6C OA3 |
| Website | https://www.xortx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
